» Articles » PMID: 8177532

Regional Differences in Apolipoprotein E Immunoreactivity in Diffuse Plaques in Alzheimer's Disease Brain

Overview
Journal Neurosci Lett
Specialty Neurology
Date 1994 Feb 14
PMID 8177532
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Apolipoprotein E (Apo E) has been shown to be closely associated with beta amyloid in Alzheimer's disease (AD) brain. In the present study, we have found strong Apo E immunoreactivity in the amyloid cores of senile plaques (SP) in the various brain regions examined. However, Apo E immunoreactivity in diffuse plaques varied distinctly and was strong within numerous cerebellar and cortical diffuse plaques, and absent or very weak within diffuse plaques in the striatum/thalamus. This distribution of Apo E immunoreactivity in SP correlates with the occurrence of small amounts of fibrillar amyloid in diffuse plaques that has been described in the cerebral and cerebellar cortex, but not in the basal ganglia. These results show that Apo E may be associated with sites of beta amyloid fibril formation in diffuse plaques in AD brain, but they also suggest that factors other than Apo E, probably local, may influence fibrillogenesis.

Citing Articles

Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus.

Woltjer R, Reese L, Richardson B, Tran H, Green S, Pham T Mol Genet Metab. 2015; 116(4):289-97.

PMID: 26547561 PMC: 4688119. DOI: 10.1016/j.ymgme.2015.10.012.


Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.

Yang J, Ji Y, Mehta P, Bates K, Sun Y, Wisniewski T J Alzheimers Dis. 2011; 24(2):269-85.

PMID: 21239853 PMC: 3132897. DOI: 10.3233/JAD-2011-101401.


Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.

Wisniewski T, Sadowski M BMC Neurosci. 2008; 9 Suppl 2:S5.

PMID: 19090993 PMC: 2604889. DOI: 10.1186/1471-2202-9-S2-S5.


Immunological and anti-chaperone therapeutic approaches for Alzheimer disease.

Wisniewski T, Frangione B Brain Pathol. 2005; 15(1):72-7.

PMID: 15779239 PMC: 8095760. DOI: 10.1111/j.1750-3639.2005.tb00102.x.


Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy S, Yang F, Irrizarry M, Hyman B, Saido T, Hsiao K Am J Pathol. 1998; 152(1):307-17.

PMID: 9422548 PMC: 1858113.